We conclude that the anti-nociceptive effect produced by blocking upregulated DRG NIS-lncRNA in neuropathic pain likely results from inactivation of the Ccl2 gene, silencing of CCL2 protein expression, and reduction of neuronal excitability, particularly in medium and large neurons of injured DRGs. Here, CCL2 is linked to neuropathic pain.